Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Araujo Lh"'
Publikováno v:
Cancer Imaging
Metastatic leiomyosarcoma has a dismal prognosis, and therapy mainly consists of palliative systemic chemotherapy. A selected subgroup of patients with limited metastatic disease may eventually derive benefit from more aggressive strategies, includin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Araujo LH; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil., Bueno Chagas TA; Pharmaceutical Science Department, Alfenas Federal University, Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Brazil., Reis T; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil., de Morais Borba JRB; Pharmaceutical Science Department, Alfenas Federal University, Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Brazil., Trujilho MNR; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil., Dalzoto LAM; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil., Marcondes MF; Department of Biophysics, São Paulo Federal University, Rua Pedro de Toledo, 669, 7° floor, 04039-032, São Paulo, Brazil., Juliano MA; Department of Biophysics, São Paulo Federal University, Rua Pedro de Toledo, 669, 7° floor, 04039-032, São Paulo, Brazil., Júdice WAS; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil., Veloso MP; Pharmaceutical Science Department, Alfenas Federal University, Rua Gabriel Monteiro da Silva, 700, 37130-001, Alfenas, Brazil., Machado MFM; Interdisciplinary Center for Biochemical Research, University of Mogi das Cruzes, Av Dr. Cândido Xavier de Almeida e Souza, 200, 08780-991, Mogi das Cruzes, Brazil. Electronic address: mauriciomachado@umc.br.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Nov 26; Vol. 735, pp. 150657. Date of Electronic Publication: 2024 Sep 05.
Autor:
Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Luft AV; Leningrad Regional Clinical Hospital, St Petersburg, Russia., Alatorre-Alexander J; Health Pharma Professional Research, Mexico City, Mexico., Geater SL; Prince of Songkla University, Songkhla, Thailand., Laktionov K; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia., Trukhin D; Odessa National Medical University, Odessa, Ukraine., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ursol GM; Acinus, Kropyvnytskyi, Ukraine., Hussein M; Florida Cancer Specialists - Sarah Cannon Research Institute, Leesburg, Florida., Lim FL; Queen Mary University of London, London, United Kingdom., Yang CT; Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Araujo LH; Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil., Saito H; Kanagawa Cancer Center, Yokohama, Japan., Reinmuth N; Asklepios Lung Clinic, member of the German Centre for Lung Research (DZL), Munich-Gauting, Germany., Lowery C; AstraZeneca, Gaithersburg, Maryland., Mann H; AstraZeneca, Cambridge, United Kingdom., Stewart R; AstraZeneca, Cambridge, United Kingdom., Jiang H; AstraZeneca, Gaithersburg, Maryland., Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, California., Mok T; Chinese University of Hong Kong, Hong Kong, People's Republic of China., Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.
Autor:
Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: egaron@mednet.ucla.edu., Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Luft A; Leningrad Regional Clinical Hospital, St Petersburg, Russia., Alatorre-Alexander J; Health Pharma Professional Research, Mexico City, Mexico., Geater SL; Prince of Songkla University, Songkhla, Thailand., Trukhin D; Odessa Regional Oncological Dispensary, Odessa, Ukraine., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Ursol G; Acinus, Kropyvnytskyi, Ukraine., Hussein M; Florida Cancer Specialists - Sarah Cannon Research Institute, Leesburg, FL., Lim FL; Queen Mary University of London, London, United Kingdom., Yang CT; Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Araujo LH; Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil., Saito H; Kanagawa Cancer Center, Yokohama, Japan., Reinmuth N; Asklepios Lung Clinic, Member of the German Center for Lung Research (DZL), Munich-Gauting, Germany., Kohlmann M; AstraZeneca, Gaithersburg, MD., Lowery C; AstraZeneca, Gaithersburg, MD., Mann H; AstraZeneca, Cambridge, United Kingdom., Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland., Mok TS; Chinese University of Hong Kong, Hong Kong, China., Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN.
Publikováno v:
Clinical lung cancer [Clin Lung Cancer] 2024 May; Vol. 25 (3), pp. 266-273.e5. Date of Electronic Publication: 2024 Mar 15.
Autor:
Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: egaron@mednet.ucla.edu., Cho BC; Yonsei Cancer Center, Seoul, Republic of Korea., Luft A; Leningrad Regional Clinical Hospital, St Petersburg, Russia., Alatorre-Alexander J; Health Pharma Professional Research, Mexico City, Mexico., Geater SL; Prince of Songkla University, Songkhla, Thailand., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Ursol G; Acinus, Kropyvnytskyi, Ukraine., Hussein M; Florida Cancer Specialists - Sarah Cannon Research Institute, Leesburg, FL, USA., Lim FL; Queen Mary University of London, London, UK., Yang CT; Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Araujo LH; Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil., Saito H; Kanagawa Cancer Center, Yokohama, Japan., Reinmuth N; Asklepios Lung Clinic, member of the German Center for Lung Research (DZL), Munich-Gauting, Germany., Medic N; AstraZeneca, Cambridge, UK., Mann H; AstraZeneca, Cambridge, UK., Shi X; AstraZeneca, Gaithersburg, MD, USA., Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland., Mok T; Chinese University of Hong Kong, Hong Kong, China., Johnson M; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Dec; Vol. 186, pp. 107422. Date of Electronic Publication: 2023 Nov 11.
Autor:
Passmore S; Evolution of Cultural Diversity Initiative (ECDI), Australian National University, Canberra, ACT, Australia.; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Faculty of Environment and Information Studies, Keio University, Fujisawa, Japan., Barth W; ARC Centre of Excellence for the Dynamics of Language (CoEDL), Australian National University, Canberra, ACT, Australia., Greenhill SJ; School of Biological Sciences, University of Auckland, Auckland, New Zealand.; Department of Linguistic and Cultural Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany., Quinn K; ARC Centre of Excellence for the Dynamics of Language (CoEDL), Australian National University, Canberra, ACT, Australia., Sheard C; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; School of Earth Sciences, University of Bristol, Bristol, United Kingdom., Argyriou P; School of Biological and Behavioural Sciences, Queen Mary University of London, London, United Kingdom., Birchall J; Museu Paraense Emílio Goeldi, Belém, Pará, Brazil.; Department of Linguistics, The University of New Mexico, New Mexico, United States of America., Bowern C; Department of Linguistics, Yale University, New Haven, Connecticut, United States of America., Calladine J; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Department of Human Behavior, Ecology and Culture, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany., Deb A; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Department of Cognitive Science, Central European University, Vienna, Austria., Diederen A; Max Planck Institute for Psycholinguistics, Nijmegen, Netherlands., Metsäranta NP; Department of Finnish, Finno-Ugrian, and Scandinavian Studies, University of Helsinki, Helsinki, Finland., Araujo LH; Department of Linguistics, Universidade Federal do Pará, Belém, Pará, Brazil., Schembri R; Research School of Biology, Ecology, and Evolution, Australian National University, Canberra, ACT, Australia., Hickey-Hall J; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom., Honkola T; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Department of Finnish, Finno-Ugrian, and Scandinavian Studies, University of Helsinki, Helsinki, Finland., Mitchell A; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Institute for African Studies, University of Cologne, Cologne, Germany., Poole L; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom., Rácz PM; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; Cognitive Science Department, Budapest University of Technology and Economics, Budapest, Hungary., Roberts SG; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.; School of English, Communications and Philosophy, Cardiff University, Cardiff, United Kingdom., Ross RM; School of Psychological Sciences, Macquarie University, Sydney, NSW, Australia., Thomas-Colquhoun E; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom., Evans N; Evolution of Cultural Diversity Initiative (ECDI), Australian National University, Canberra, ACT, Australia.; ARC Centre of Excellence for the Dynamics of Language (CoEDL), Australian National University, Canberra, ACT, Australia., Jordan FM; Department of Anthropology and Archaeology, University of Bristol, Bristol, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2023 May 24; Vol. 18 (5), pp. e0283218. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023).
Autor:
Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN., Cho BC; Yonsei Cancer Center, Seoul, South Korea., Luft A; Leningrad Regional Clinical Hospital, St Petersburg, Russia., Alatorre-Alexander J; Health Pharma Professional Research, Mexico City, Mexico., Geater SL; Prince of Songkla University, Songkhla, Thailand., Laktionov K; Federal State Budgetary Institution 'N.N. Blokhin National Medical Research Center of Oncology' of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Ursol G; Acinus, Kropyvnytskyi, Ukraine., Hussein M; Florida Cancer Specialists-Sarah Cannon Research Institute, Leesburg, FL., Lim FL; Queen Mary University of London, London, United Kingdom., Yang CT; Chang Gung Memorial Hospital, Taoyuan City, Taiwan., Araujo LH; Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil., Saito H; Kanagawa Cancer Center, Yokohama, Japan., Reinmuth N; Asklepios Lung Clinic, member of the German Center for Lung Research (DZL), Munich-Gauting, Germany., Shi X; AstraZeneca, Gaithersburg, MD., Poole L; AstraZeneca, Cambridge, United Kingdom., Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland., Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, CA., Mok T; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 20; Vol. 41 (6), pp. 1213-1227. Date of Electronic Publication: 2022 Nov 03.
Autor:
Faroni L; Instituto COI de Pesquisa e Ensino, Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil., Ferreira CG; Oncoclínicas, Rio de Janeiro, Brazil., Moraes F; Department of Oncology, Kingston General Hospital Queens University, Ontario, Canada., Baldotto C; Instituto COI de Pesquisa e Ensino, Rio de Janeiro, Brazil.; Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil., Zukin M; Instituto COI de Pesquisa e Ensino, Rio de Janeiro, Brazil., Aran V; Instituto Estadual do Cérebro Paulo Niemeyer (IECPN), Rio de Janeiro, Brazil., Araujo LH; Instituto COI de Pesquisa e Ensino, Rio de Janeiro, Brazil.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2022 Nov; Vol. 8, pp. e2200061.
Autor:
Ominelli J; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil. Electronic address: juominelli@hotmail.com., Araujo ROC; Department of Abdomino-Pelvic Surgery, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Valadão M; Department of Abdomino-Pelvic Surgery, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Padoan MLA; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Lopes Dos Santos VM; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Dutra JG; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Torres CC; Department of Radiology, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Barbosa MA; Department of Radiology, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Guimarães R; Department of Radiotherapy, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Carvalho JCC; Department of Radiotherapy, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Ferreira MA; Department of Endoscopy, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., de Oliveira IM; Department of Pathology, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Small I; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., de Melo AC; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil., Araujo LH; Division of Clinical Research, Instituto Nacional de Câncer (INCA), Rio de Janeiro (RJ), Brazil.
Publikováno v:
Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Sep; Vol. 21 (3), pp. e196-e204. Date of Electronic Publication: 2022 May 13.